Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antiscorpion Venom Serum (Haffkine Bio-Pharmaceutical Corporation Ltd.)
- Development stage
- Unknown
- Lead developer
- Haffkine Bio-Pharmaceutical Corporation
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Antiscorpion Venom Serum (AScVS) is a monovalent, enzyme-refined biologic developed by Haffkine Bio-Pharmaceutical Corporation Ltd. for the treatment of envenomation by the Indian red scorpion (*Mesobuthus tamulus*). It consists of purified equine F(ab)2 immunoglobulin fragments obtained from horses immunized against the specific scorpion venom. The serum works by binding to and neutralizing the circulating neurotoxins, preventing their interaction with physiological targets. Introduced in 1997, it was the first specific antivenom available in India for this indication and has been studied in clinical trials both as a monotherapy and in combination with prazosin to improve clinical outcomes in severe cases.
- Brand names
- Antiscorpion Venom Serum
- Other names
- Scorpion AntivenomRed Scorpion AntivenomHaffkine Scorpion AntivenomAntiscorpion Venom Serum (AScVS)
Beyond the preview
Go deeper on Antiscorpion Venom Serum (Haffkine Bio-Pharmaceutical Corporation Ltd.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antiscorpion Venom Serum (Haffkine Bio-Pharmaceutical Corporation Ltd.).